He, H., Gao, Y., Fu, J., Zhou, Q., Wang, X., Bai, B., . . . Huang, H. (2021). VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma. Oncoimmunology.
Chicago Style citaatHe, Hai-Xia, et al. "VISTA and PD-L1 Synergistically Predict Poor Prognosis in Patients With Extranodal Natural Killer/T-cell Lymphoma." Oncoimmunology 2021.
MLA citatieHe, Hai-Xia, et al. "VISTA and PD-L1 Synergistically Predict Poor Prognosis in Patients With Extranodal Natural Killer/T-cell Lymphoma." Oncoimmunology 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.